Rose B. McGee, MS, CGC

Rose B. McGee, MS, CGC

  • Certified Genetic Counselor II




BS – Biology, University of Tampa, Tampa, Florida
MS – Equine Genetics, University of Kentucky, Lexington, Kentucky
MS – Genetic Counseling, University of Pittsburgh, Pittsburgh, Pennsylvania

Honors and Awards

  • 2013 Outstanding Student Award, Department of Human Genetics, University of Pittsburgh

Professional Organizations

  • National Society of Genetic Counselors full member
  • National Society of Genetic Counselors Cancer Special Interest Group, Pediatric Subcommittee
  • Li-Fraumeni Syndrome Association Genetic Counseling Advisory Group
  • Tennessee Genetic Counselors Association

Research Interests

I am a pediatric cancer genetic counselor with interests in:

  • Identification, surveillance and genotype-phenotype correlations of cancer predisposition syndromes. Syndromes of particular interest are constitutional mismatch repair deficiency (CMMRD) syndrome and DICER1 syndrome
  • Incorporation of clinical genomics into pediatric cancer care
  • Communication of complex information to children of varying ages, assessing impact of illness on the family and pre-symptomatic testing of minors for cancer predisposition

Selected Publications

Johnson LM, Sykes AD, Lu Z, Valdez JM, Gattuso J, Gerhardt E, Hamilton KV, Harrison LW,  Hines‐Dowell SJ, Jurbergs N, McGee RB, Nuccio R, Ouma AA, Pritchard M, Quinn EA, Baker JN, Mandrell BN, Nichols KE. Speaking genomics to parents offered germline testing for cancer predisposition: Use of a 2‐visit consent model. Cancer. 2019 Jul 15;125(14):2455-2464 2019

Burges M, King B, McGee R, Brennan R& Wilson M. Unilateral retinoblastoma in a patient with Hermansky-Pudlak syndrome, Ophthalmic Genetics, 40:1, 83-85, 2019.

Rusch M, Nakitandwe J, Shurtleff S, Newman S, Zhang Z, Edmonson MN, Parker M, Jiao Y, Ma X, Liu Y, Gu J, Walsh MF, Becksfort J, Thrasher A, Li Y, McMurry J, Hedlund E, Patel A, Easton J, Yergeau D, Vadodaria B, Tatevossian RG, Raimondi S, Hedges D, Chen X, Hagiwara K, McGee R, Robinson GW, Klco JM, Gruber TA, Ellison DW, Downing JR, Zhang J. Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome. Nature Communications 9, 3962 (2018) doi:10.1038/s41467-018-06485-7, 2018.

Upadhyaya SA, McGee RB, Wilky BA, Broniscer A. Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome. Pediatr Blood Cancer 65:e27030-, 2018.

Lucas JT, McGee R, Billups CA, Qaddoumi I, Merchant TE, Brennan RC, Wu J, Wilson MW. Prior non-irradiative focal therapies do not compromise the efficacy of delayed episcleral plaque brachytherapy in retinoblastoma. Br J Ophthalmol  2018.

Schwartz JR, Wang S, Ma J, Lamprecht T, Walsh M, Song G, Raimondi SC, Wu G, Walsh MF, McGee RB, Kesserwan C, Nichols KE, Cauff BE, Ribeiro RC, Wlodarski M, Klco JM. Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome. Leukemia 31:1827-1830, 2017.

Druker H, Zelley K, McGee RB, Scollon SR, Kohlmann WK, Schneider KA, Wolfe Schneider K. Genetic Counselor Recommendations for Cancer Predisposition Evaluation and Surveillance in the Pediatric Oncology Patient. Clin Cancer Res 23:e91-e97, 2017.

Johnson LM, Valdez JM, Quinn EA, Sykes AD, McGee RB, Nuccio R, Hines-Dowell SJ, Baker JN, Kesserwan C, Nichols KE, Mandrell BN. Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics. Cancer 123:2352-2359, 2017.

Schultz KAP, Rednam SP, Kamihara J, Doros L, Achatz MI, Wasserman JD, Diller LR, Brugieres L, Druker H, Schneider KA, McGee RB, Foulkes WD. PTEN, DICER1, FH, and their associated tumor susceptibility syndromes: Clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res 23:e76-e82, 2017.

Kratz CP, Achatz MI, Brugieres L, Frebourg T, Garber JE, Greer MC, Hansford JR, Janeway KA, Kohlmann WK, McGee R, Mullighan CG, Onel K, Pajtler KW, Pfister SM, Savage SA, Schiffman JD, Schneider KA, Strong LC, Evans DGR, Wasserman JD, Villani A, Malkin D. Cancer screening recommendations for individuals with Li-Fraumeni syndrome. Clin Cancer Res 23:e38-e45, 2017.

McGee RB, Nichols KE. Introduction to cancer genetic susceptibility syndromes. Hematology Am Soc Hematol Educ Program Dec 2;2016(1):293-301, 2016.

Alexander TB, McGee RB, Kaye EC, McCarville MB, Choi JK, Cavender CP, Nichols KE, Sandlund JT. Metachronous T-Lymphoblastic Lymphoma and Burkitt Lymphoma in a Child With Constitutional Mismatch Repair Deficiency Syndrome. Pediatr Blood Cancer Aug;63(8):1454-6, 2016.

Davidson JT, Lam CG, McGee RB, Bahrami A, Diaz-Thomas A. Parathyroid Cancer in the Pediatric Patient. J Pediatr Hematol Oncol Jan;38(1):32-7, 2016.

Topka S, Vijai J, Walsh MF, Jacobs L, Maria A, Villano D, Gaddam P, Wu G, McGee RB, Quinn E, Inaba H, Hartford C, Pui CH, Pappo A, Edmonson M, Zhang MY, Stepensky P, Steinherz P, Schrader K, Lincoln A, Bussel J, Lipkin SM, Goldgur Y, Harit M, Stadler ZK, Mullighan C, Weintraub M, Shimamura A, Zhang J, Downing JR, Nichols KE, Offit K. Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia. PLoS Genet Jun 23;11(6):e1005262, 2015.

Quinn E, McGee R, Nuccio R, Pappo AS, Nichols KE. Genetic Predisposition to Neonatal Tumors. Curr Pediatr Rev 2015;11(3):164-78. Review.  

Zhang J*, Walsh MF*, Wu G*, Edmonson MN, Gruber TA, Easton J, Hedges D, Ma X, Zhou X, Yergeau DA, Wilkinson MR, Vadodaria B, Chen X, McGee RB, Hines-Dowell S, Nuccio R, Quinn E, Shurtleff SA, Rusch M, Patel A, Becksfort JB, Wang S, Weaver MS, Ding L, Mardis ER, Wilson RK, Gajjar A, Ellison DW, Pappo AS, Pui CH, Nichols KE*, Downing JR. Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med Nov 18, 2015. Epub ahead of print. doi:10.1056/NEJMoa1508054. *Equal contribution

Last update: November 2019

For updates on COVID-19, please read.